ARCHIVES

MEPACT Approved In Europe For Resectable Osteosarcoma

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Director Sets A Goal: Eliminate Suffering, Death From Cancer By 2015

February 14, 2003

NCI awards $42 million for prevention trials consortium.

December 5, 2003

Hudis’s Address At ASCO 2014: On Value & Commitment

June 6, 2014

Competing Strategies For Breast Cancer? Brinker Tries to Ensure acceptance Of Report, Visco Urges Broad Effort

October 8, 1993

Henschke and Supporters Call For Urgent Action Based On Results Of NLST

May 13, 2011

Obama Plan Would Double Cancer Funding, Increase Clinical Trial Enrollment To 10%.

November 7, 2008